Marker Therapeutics, Inc.
(NASDAQ : MRKR)

( )
MRKR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Consumer Services » Other Consumer Services
symbolcompany%chnglast%shortavg$volume
BKNGBooking Holdings, Inc. 5.03%1424.870.0%$1177.15m
EBAYeBay, Inc. 3.02%32.122.2%$533.76m
EXPEExpedia Group, Inc. 11.21%58.757.4%$341.18m
CTASCintas Corp. 0.00%179.494.6%$257.30m
EDUNew Oriental Education & Technology Group, Inc. 1.33%112.461.3%$247.62m
TALTAL Education Group 2.27%55.000.8%$232.49m
PTONPeloton Interactive, Inc. 2.61%29.110.0%$225.71m
TCOMTrip.com Group Ltd. 5.08%24.640.0%$217.79m
PLNTPlanet Fitness, Inc. 8.85%46.2512.7%$193.10m
SCIService Corp. International 3.84%38.655.1%$87.03m
ROLRollins, Inc. 0.00%37.202.6%$82.57m
AYTUAytu BioScience, Inc. 1.91%1.600.0%$76.41m
TRIPTripAdvisor, Inc. 7.21%18.0013.2%$73.98m
HRBH&R Block, Inc. 2.21%13.8511.9%$67.05m
VACMarriott Vacations Worldwide Corp. 11.02%64.408.2%$62.44m

Company Profile

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.